back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-04-02 16:07 Tx date 2022-03-31 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,973
+6,800 vol $1.47 each |
123,786 | |
| Filed 2022-01-05 16:46 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+80,250 vol |
195,750 | |
| Filed 2022-01-05 16:44 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+53,500 vol |
383,408 | |
| Filed 2021-06-24 11:56 Tx date 2021-06-23 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,218
+2,200 vol $1.46 each |
116,986 | |
| Filed 2021-06-24 11:53 Tx date 2021-06-22 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,904
+2,700 vol $1.45 each |
114,786 | |
| Filed 2021-06-22 15:45 Tx date 2021-06-21 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,871
+2,000 vol $1.44 each |
112,086 | |
| Filed 2021-03-23 11:50 Tx date 2021-03-22 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,849
+4,700 vol $1.67 each |
110,086 | |
| Filed 2021-03-23 11:43 Tx date 2020-03-27 |
$MRV
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
299,908 | |
| Filed 2020-03-27 16:05 Tx date 2020-03-27 |
$MRV
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
||
| Filed 2021-03-18 09:32 Tx date 2021-03-16 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,062
+6,500 vol $1.86 each |
105,386 | |
| Filed 2021-03-12 16:08 Tx date 2021-03-11 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+115,500 vol |
115,500 | |
| Filed 2021-03-12 16:02 Tx date 2016-04-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-12 15:59 Tx date 2021-03-11 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
329,908 | |
| Filed 2020-06-17 12:47 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+1,500 vol $0.80 each |
98,886 | |
| Filed 2020-06-17 12:46 Tx date 2020-06-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
97,386 | |
| Filed 2020-06-15 16:54 Tx date 2020-06-12 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,975
+2,500 vol $0.79 each |
94,886 | |
| Filed 2020-06-12 13:23 Tx date 2020-06-11 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
92,386 | |
| Filed 2020-06-11 13:56 Tx date 2020-06-10 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
89,886 | |
| Filed 2020-06-10 13:25 Tx date 2020-06-09 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
87,386 | |
| Filed 2020-06-09 13:40 Tx date 2020-06-08 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
84,886 | |
| Filed 2020-06-08 16:05 Tx date 2020-06-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,955
+2,500 vol $0.78 each |
82,386 | |
| Filed 2020-06-05 12:21 Tx date 2020-06-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
79,886 | |
| Filed 2020-06-04 12:09 Tx date 2020-06-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,870
+2,500 vol $0.75 each |
77,386 | |
| Filed 2020-06-03 17:42 Tx date 2020-06-02 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
74,886 | |
| Filed 2020-06-02 17:27 Tx date 2020-06-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,955
+2,500 vol $0.78 each |
72,386 | |
| Filed 2020-06-01 16:17 Tx date 2020-05-29 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
69,886 | |
| Filed 2020-05-29 15:38 Tx date 2020-05-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,060
+2,500 vol $0.82 each |
67,386 | |
| Filed 2020-05-28 15:49 Tx date 2020-05-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
64,886 | |
| Filed 2020-05-28 15:46 Tx date 2020-05-26 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
62,386 | |
| Filed 2020-05-26 17:20 Tx date 2020-05-25 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,975
+2,500 vol $0.79 each |
59,886 | |
| Filed 2020-05-25 14:53 Tx date 2020-05-22 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
57,386 | |
| Filed 2020-05-22 12:54 Tx date 2020-05-21 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
54,886 | |
| Filed 2020-05-21 15:01 Tx date 2020-05-20 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
52,386 | |
| Filed 2020-05-20 16:46 Tx date 2020-05-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,750
+2,500 vol $0.70 each |
49,886 | |
| Filed 2020-05-19 15:14 Tx date 2020-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,675
+2,500 vol $0.67 each |
47,386 | |
| Filed 2020-05-15 12:28 Tx date 2020-05-14 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,825
+2,500 vol $0.73 each |
44,886 | |
| Filed 2020-03-27 16:05 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
299,908 | |
| Filed 2020-03-27 15:58 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,680
+2,500 vol $0.67 each |
42,386 | |
| Filed 2020-03-27 15:58 Tx date 2020-03-25 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,625
+2,500 vol $0.65 each |
39,886 | |
| Filed 2020-03-25 18:15 Tx date 2020-03-24 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,625
+2,500 vol $0.65 each |
37,386 | |
| Filed 2020-03-24 10:31 Tx date 2020-03-23 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,525
+2,500 vol $0.61 each |
34,886 | |
| Filed 2020-03-20 12:38 Tx date 2020-03-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,830
+2,500 vol $0.73 each |
32,386 | |
| Filed 2020-03-17 15:14 Tx date 2020-03-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,875
+2,500 vol $0.75 each |
29,886 | |
| Filed 2020-03-16 17:05 Tx date 2020-03-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,795
+2,500 vol $0.72 each |
27,386 | |
| Filed 2020-03-12 16:23 Tx date 2020-03-11 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
24,886 | |
| Filed 2020-03-11 11:02 Tx date 2020-03-10 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,265
+2,500 vol $0.91 each |
22,386 | |
| Filed 2020-03-09 14:56 Tx date 2020-03-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,080
+2,500 vol $0.83 each |
19,886 | |
| Filed 2020-03-05 11:23 Tx date 2020-03-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,415
+2,500 vol $0.97 each |
17,386 | |
| Filed 2019-04-16 10:10 Tx date 2019-04-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,000 vol |
199,908 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$301.00
+100 vol $3.01 each |
11,986 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,788
+600 vol $2.98 each |
11,886 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,564
+1,200 vol $2.97 each |
11,286 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$304.00
+100 vol $3.04 each |
12,286 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$305.00
+100 vol $3.05 each |
12,386 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$306.00
+100 vol $3.06 each |
12,486 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$307.00
+100 vol $3.07 each |
12,586 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$308.00
+100 vol $3.08 each |
12,686 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$309.00
+100 vol $3.09 each |
12,786 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$310.00
+100 vol $3.10 each |
12,886 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$311.00
+100 vol $3.11 each |
12,986 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,652
+1,800 vol $3.14 each |
14,786 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$303.00
+100 vol $3.03 each |
12,186 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$318.00
+100 vol $3.18 each |
14,886 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$302.00
+100 vol $3.02 each |
12,086 | |
| Filed 2018-03-29 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$29,999
+8,086 vol $3.71 each |
10,086 | |
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
154,908 | |
| Filed 2017-03-08 Tx date 2017-03-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+71,083 vol |
104,908 | |
| Filed 2016-12-23 Tx date 2016-12-20 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,020
+2,000 vol $6.51 each |
2,000 | |
| Filed 2016-12-23 Tx date 2016-04-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-05 Tx date 2016-04-04 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
33,825 |